NCT04316247

Brief Summary

The investigators will retrospectively study the demographic , clinicopathological characteristics and survival of breast cancer patients admitted to Assiut University hospital from the year 2015 to 2019

Trial Health

35
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
100

participants targeted

Target at P50-P75 for all trials

Timeline
Completed

Started Apr 2021

Typical duration for all trials

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

March 16, 2020

Completed
4 days until next milestone

First Posted

Study publicly available on registry

March 20, 2020

Completed
1 year until next milestone

Study Start

First participant enrolled

April 1, 2021

Completed
2.8 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 31, 2023

Completed
1 year until next milestone

Study Completion

Last participant's last visit for all outcomes

December 31, 2024

Completed
Last Updated

March 23, 2020

Status Verified

March 1, 2020

Enrollment Period

2.8 years

First QC Date

March 16, 2020

Last Update Submit

March 19, 2020

Conditions

Breast Carcinoma

Outcome Measures

Primary Outcomes (1)

  • The survival rate of breast cancer in assiut university hospital

    The number of patients survived after surgery or chemotherapy

    One year

Eligibility Criteria

Age18 Years - 90 Years
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

Retrospective study on breast cancer patients : A single institution study

You may qualify if:

  • All histologically confirmed and documented patients with invasive ductal or lobular carcinoma of the breast attending at Assiut University hospital from year 2015 to 2019.

You may not qualify if:

  • Patients who previously received treatment outside Assiut University hospital.
  • A serious un controlled concomitant disease that would contraindicate with use of systemic treatment. .

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Related Publications (1)

  • Chen S, Chen H, Yi Y, Jiang X, Lei H, Luo X, Chen Y, Liu S, Yuan D, Jia X, Li J. Comparative study of breast cancer with or without concomitant Paget disease: An analysis of the SEER database. Cancer Med. 2019 Jul;8(8):4043-4054. doi: 10.1002/cam4.2242. Epub 2019 May 28.

    PMID: 31134761RESULT

MeSH Terms

Conditions

Breast Neoplasms

Condition Hierarchy (Ancestors)

Neoplasms by SiteNeoplasmsBreast DiseasesSkin DiseasesSkin and Connective Tissue Diseases

Study Officials

  • Samir E Shehata, Professor

    Assiut University

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Neveen N Kamel, doctor

CONTACT

+201287668559neveenemanuel@gmail.com

Summar M El Morshidy, Lecturer

CONTACT

+201063030750Summerelmorshidy@yahoo.com

Study Design

Study Type
observational
Observational Model
CASE CONTROL
Time Perspective
RETROSPECTIVE
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Principal investigator

Study Record Dates

First Submitted

March 16, 2020

First Posted

March 20, 2020

Study Start

April 1, 2021

Primary Completion

December 31, 2023

Study Completion

December 31, 2024

Last Updated

March 23, 2020

Record last verified: 2020-03